D
Diane Warden
Researcher at University of Texas Southwestern Medical Center
Publications - 58
Citations - 6188
Diane Warden is an academic researcher from University of Texas Southwestern Medical Center. The author has contributed to research in topics: Major depressive disorder & Randomized controlled trial. The author has an hindex of 33, co-authored 58 publications receiving 5661 citations.
Papers
More filters
Journal ArticleDOI
Medication Augmentation after the Failure of Ssris for Depression
Madhukar H. Trivedi,Maurizio Fava,Stephen R. Wisniewski,Michael E. Thase,Frederick M. Quitkin,Diane Warden,Louise Ritz,Andrew A. Nierenberg,Barry D. Lebowitz,Melanie M. Biggs,James F. Luther,Kathy Shores-Wilson,A. John Rush +12 more
TL;DR: Augmentation of citalopram with either sustained-release bupropion or buspirone appears to be useful in actual clinical settings, including a greater reduction in the number and severity of symptoms and fewer side effects and adverse events.
Journal ArticleDOI
Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.
A. John Rush,Madhukar H. Trivedi,Stephen R. Wisniewski,Jonathan W. Stewart,Andrew A. Nierenberg,Michael E. Thase,Louise Ritz,Melanie M. Biggs,Diane Warden,James F. Luther,Kathy Shores-Wilson,George Niederehe,Maurizio Fava +12 more
TL;DR: After unsuccessful treatment with an SSRI, approximately one in four patients had a remission of symptoms after switching to another antidepressant, suggesting any one of the medications in the study provided a reasonable second-step choice for patients with depression.
Journal ArticleDOI
The STAR*D project results: A comprehensive review of findings
TL;DR: Prognosis was better at all levels for participants who entered follow-up in remission as opposed to those who entered with response without remission, highlighting the prevalence of treatment-resistant depression and suggesting potential benefit for using more vigorous treatments in the earlier steps.
Journal ArticleDOI
Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: a STAR*D report.
Michael E. Thase,Edward S. Friedman,Melanie M. Biggs,Stephen R. Wisniewski,Madhukar H. Trivedi,James F. Luther,Maurizio Fava,Andrew A. Nierenberg,Patrick J. McGrath,Diane Warden,George Niederehe,Steven D. Hollon,A. John Rush +12 more
TL;DR: Pharmacologic augmentation was more rapidly effective than cognitive therapy augmentation of citalopram, whereas switching to cognitive therapy was better tolerated than switching to a different antidepressant.
Journal ArticleDOI
Combining Medications to Enhance Depression Outcomes (CO-MED): Acute and Long-Term Outcomes of a Single-Blind Randomized Study
A. John Rush,Madhukar H. Trivedi,Jonathan W. Stewart,Andrew A. Nierenberg,Maurizio Fava,Benji T. Kurian,Diane Warden,David W. Morris,James F. Luther,Mustafa M. Husain,Ian A. Cook,Richard C. Shelton,Ira M. Lesser,Susan G. Kornstein,Stephen R. Wisniewski +14 more
TL;DR: Two antidepressant medication combinations were compared with selective serotonin reuptake inhibitor monotherapy to determine whether either combination produced a higher remission rate in first-step acute-phase (12 weeks) and long-term (7 months) treatment.